Cysteine misincorporation in bacterially expressed human α-synuclein

被引:68
作者
Masuda, M
Dohmae, N
Nonaka, T
Oikawa, T
Hisanaga, SI
Goedert, M
Hasegawa, M
机构
[1] Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan
[2] Tokyo Metropolitan Univ, Grad Sch Sci, Mol Neurosci Lab, Tokyo 1920397, Japan
[3] RIKEN, Biomol Characterizat, Wako, Saitama 3510198, Japan
[4] Med Res Council Lab Mol Biol, Cambridge CB2 2QH, England
基金
英国医学研究理事会;
关键词
alpha-synuclein; mistranslation; cysteine; dimerization; aggregation;
D O I
10.1016/j.febslet.2006.02.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacterially expressed human a-synuclein (alpha-syn) has been widely used in structural and functional studies. Here we show that similar to 20% of human a-syn expressed in Escherichia coli is mistranslated and that a Cys residue is incorporated at position 136 instead of a Tyr. Site-directed mutagenesis of codon 136 (TAC to TAT) resulted in the expression of a-syn lacking Cys. Although wild-type (Y136-TAC and Y136-TAT) and mutant (C136-TGC) alpha-syn had similar propensities to assemble into filaments, the levels of dimeric alpha-syn were increased by misincorporation. To avoid potential artefacts, we recommend use of the Y136-TAT construct for the expression of human alpha-syn. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1775 / 1779
页数:5
相关论文
共 17 条
[1]   Mutation E46K increases phospholipid binding and assembly into filaments of human α-synuclein [J].
Choi, W ;
Zibaee, S ;
Jakes, R ;
Serpell, LC ;
Davletov, B ;
Crowther, RA ;
Goedert, M .
FEBS LETTERS, 2004, 576 (03) :363-368
[2]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[3]   Gene dosage and pathogenesis of Parkinson's disease [J].
Eriksen, JL ;
Przedborski, S ;
Petrucelli, L .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (03) :91-96
[4]   α-Synuclein is phosphorylated in synucleinopathy lesions [J].
Fujiwara, H ;
Hasegawa, M ;
Dohmae, N ;
Kawashima, A ;
Masliah, E ;
Goldberg, MS ;
Shen, J ;
Takio, K ;
Iwatsubo, T .
NATURE CELL BIOLOGY, 2002, 4 (02) :160-164
[5]   Alpha-synuclein and neurodegenerative diseases [J].
Goedert, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (07) :492-501
[6]   Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions [J].
Hasegawa, M ;
Fujiwara, H ;
Nonaka, T ;
Wakabayashi, K ;
Takahashi, H ;
Lee, VMY ;
Trojanowski, JQ ;
Mann, D ;
Iwatsubo, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :49071-49076
[7]   IDENTIFICATION OF 2 DISTINCT SYNUCLEINS FROM HUMAN BRAIN [J].
JAKES, R ;
SPILLANTINI, MG ;
GOEDERT, M .
FEBS LETTERS, 1994, 345 (01) :27-32
[8]   Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease α-synuclein fibrillogenesis [J].
Krishnan, S ;
Chi, EY ;
Wood, SJ ;
Kendrick, BS ;
Li, C ;
Garzon-Rodriguez, W ;
Wypych, J ;
Randolph, TW ;
Narhi, LO ;
Biere, AL ;
Citron, M ;
Carpenter, JF .
BIOCHEMISTRY, 2003, 42 (03) :829-837
[9]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[10]   Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J].
Polymeropoulos, MH ;
Lavedan, C ;
Leroy, E ;
Ide, SE ;
Dehejia, A ;
Dutra, A ;
Pike, B ;
Root, H ;
Rubenstein, J ;
Boyer, R ;
Stenroos, ES ;
Chandrasekharappa, S ;
Athanassiadou, A ;
Papapetropoulos, T ;
Johnson, WG ;
Lazzarini, AM ;
Duvoisin, RC ;
DiIorio, G ;
Golbe, LI ;
Nussbaum, RL .
SCIENCE, 1997, 276 (5321) :2045-2047